One of the perks of living in Los Angeles seems to be the opportunity to attend early screenings of films. Recently, I watched a documentary feature about a breakthrough at the intersection of gender equity, healthcare and bioelectric engineering. The film traces the story of a remarkable Indian innovation, supported by significant clinical data, based on a technology first published in 1979 by its inventor, Dr. Sujoy Guha, and his colleagues.
As a young biomedical engineering student in 2013, I attended a lecture by Dr. Guha. He was introduced to us as one of India's first biomedical engineers and a pioneer in bioengineering for reproductive medicine. For me, he was the first person I had heard speak about applying bioelectric phenomena in medical technology. The idea caught my attention and clearly left a lasting impression. I am still a researcher in bioelectricity and an enthusiast of medical technology. Interestingly, the technology itself is precisely that: a bioelectric solution to a medical challenge.
Briefly, the technology, known as RISUG (Reversible Inhibition of Sperm Under Guidance), involves injecting a hydrogel into the vas deferens, the tube that carries sperm. In a conventional vasectomy, this tube is cut or blocked. The hydrogel creates electrical and pH-related stress that damages or disables sperm cells as they pass through it, thereby preventing fertilisation. The gel can also be flushed out using specific solvents, making the procedure potentially reversible.
The technology has completed clinical trials and has demonstrated more than 99 per cent effectiveness in preventing pregnancies, without serious reported side effects. The documentary, Give It a Shot, does an excellent job of following the development and progress of this concept, which has been described as the first major new approach to male contraception in nearly 200 years.
The film strikes a balance between a lighthearted presentation and the seriousness of its subject. It takes viewers into the laboratories where scientists conducted in-vitro studies and cellular imaging, allowing them to observe how the technology works. It also explores the settings in which the technology underwent further validation and features intimate conversations with couples who participated in the clinical trials.
During my undergraduate years, I also had the opportunity to volunteer with an industry mentor, D.L. Pandya, at medical device conferences in Ahmedabad, Gujarat. He regularly invited medical technology pioneers from across India, including Dr. Guha, to these gatherings. This was also a period when Stanford's Biodesign Initiative was gaining momentum in India. Such experiences helped me understand that building an effective ecosystem connecting laboratory research with clinical application is just as important as developing the innovation itself.
An invention can be scientifically promising, but its journey from the laboratory to widespread clinical use requires sustained institutional support, regulatory progress, investment and public awareness. The success of any medical technology ultimately depends not only on its scientific merits but also on its accessibility and adoption.
I hope Give It a Shot brings greater public attention to this remarkable Indian innovation and provides the impetus needed to accelerate its wider adoption. A technology with the potential to expand contraceptive choices and contribute to greater gender equity deserves serious attention.
---
*R&D engineer based in Los Angeles
Comments